Risk of malignancy in 22q11.2 deletion syndrome

22q11.2DS is a significant health problem because of its fairly high incidence. It is relevant to be vigilant regarding the diagnosis of cancer amongst 22q11.2 patients as there might be an increased risk, especially amongst patients with the 22q11.2 distal deletion syndrome.

Detalles Bibliográficos
Autores principales: Stevens, Toer, van der Werff ten Bosch, Jutte, De Rademaeker, Marjan, Van Den Bogaert, Ann, van den Akker, Machiel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378830/
https://www.ncbi.nlm.nih.gov/pubmed/28396774
http://dx.doi.org/10.1002/ccr3.880
_version_ 1782519488627867648
author Stevens, Toer
van der Werff ten Bosch, Jutte
De Rademaeker, Marjan
Van Den Bogaert, Ann
van den Akker, Machiel
author_facet Stevens, Toer
van der Werff ten Bosch, Jutte
De Rademaeker, Marjan
Van Den Bogaert, Ann
van den Akker, Machiel
author_sort Stevens, Toer
collection PubMed
description 22q11.2DS is a significant health problem because of its fairly high incidence. It is relevant to be vigilant regarding the diagnosis of cancer amongst 22q11.2 patients as there might be an increased risk, especially amongst patients with the 22q11.2 distal deletion syndrome.
format Online
Article
Text
id pubmed-5378830
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-53788302017-04-10 Risk of malignancy in 22q11.2 deletion syndrome Stevens, Toer van der Werff ten Bosch, Jutte De Rademaeker, Marjan Van Den Bogaert, Ann van den Akker, Machiel Clin Case Rep Case Reports 22q11.2DS is a significant health problem because of its fairly high incidence. It is relevant to be vigilant regarding the diagnosis of cancer amongst 22q11.2 patients as there might be an increased risk, especially amongst patients with the 22q11.2 distal deletion syndrome. John Wiley and Sons Inc. 2017-03-02 /pmc/articles/PMC5378830/ /pubmed/28396774 http://dx.doi.org/10.1002/ccr3.880 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Stevens, Toer
van der Werff ten Bosch, Jutte
De Rademaeker, Marjan
Van Den Bogaert, Ann
van den Akker, Machiel
Risk of malignancy in 22q11.2 deletion syndrome
title Risk of malignancy in 22q11.2 deletion syndrome
title_full Risk of malignancy in 22q11.2 deletion syndrome
title_fullStr Risk of malignancy in 22q11.2 deletion syndrome
title_full_unstemmed Risk of malignancy in 22q11.2 deletion syndrome
title_short Risk of malignancy in 22q11.2 deletion syndrome
title_sort risk of malignancy in 22q11.2 deletion syndrome
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378830/
https://www.ncbi.nlm.nih.gov/pubmed/28396774
http://dx.doi.org/10.1002/ccr3.880
work_keys_str_mv AT stevenstoer riskofmalignancyin22q112deletionsyndrome
AT vanderwerfftenboschjutte riskofmalignancyin22q112deletionsyndrome
AT derademaekermarjan riskofmalignancyin22q112deletionsyndrome
AT vandenbogaertann riskofmalignancyin22q112deletionsyndrome
AT vandenakkermachiel riskofmalignancyin22q112deletionsyndrome

Ejemplares similares